London South East Oil & Gas Investor Briefing with guests from Coro Energy & Eco Atlantic Oil & Gas - Book Now

Less Ads, More Data, More Tools Register for FREE

City Of London Investment Trust Posts Full-Year Rise Net Assets Rise

Fri, 20th Sep 2019 10:36

(Alliance News) - City Of London Investment Trust PLC on Friday reported a rise in net assets and outperformed its benchmark indices during its recently ended financial year.

Net assets at June 30 rose by 4.9% year-on-year to GBP1.60 billion from GBP1.52 million. Net asset value per share however fell by 1.9% to 421.20 pence from 429.20p, reflecting a larger number of shares in issue.

At June 30, the trust had 378.8 million issued shares, 6.9% higher than 354.4 million at the end of the last financial year.

The company's stock was trading flat at 418.95p each in London on Friday morning.

Net asset value total return was "modest" at 2.7%, the trust said, down on 6.3% last year but outperforming its three benchmarks. The AIC UK Equity Income had a return of negative 0.8%, the IA UK Equity Income OEIC had a negative return of 2.6%, and the FTSE All-Share Index returned 0.6%.

The three largest portfolio contributors were Switzerland's Nestle SA and the US's Merck & Co Inc and Verizon Communications Inc. The best UK contributor was bakery retailer Greggs PLC, City of London said.

The biggest detractors were drug firm AstraZeneca PLC and travel operator TUI AG, both London-listed firms.

The trust hiked its annual dividend, the 53rd successive year it has done so, by 5.1% to 18.6p per share from 17.7p. City Of London said the increase was "well ahead of inflation".

Looking ahead, although the trust is wary of the impact of Brexit, a fall in sterling could be beneficial given the "predominance of international companies" in its portfolio.

Related Shares

More News

Ex-divs to take 1.4 points off FTSE 100 on Oct 24

MILAN, Oct 21 (Reuters) - The following FTSE 100 companies will go ex-dividend on Thursday, after which investors will no longer qualify for the latest dividend payout. According to Reuters calculations at current market prices, the effe...

Today 09:23

TOP NEWS: AstraZeneca's Farxiga Granted US Heart Failure Risk Approval

TOP NEWS: AstraZeneca's Farxiga Granted US Heart Failure Risk Approval

Today 08:41

LONDON MARKET PRE-OPEN: S&N CEO Departs; Candy Eyes Capital & Counties

LONDON MARKET PRE-OPEN: S&N CEO Departs; Candy Eyes Capital & Counties

Today 07:42

FDA approves AstraZeneca drug for heart failure risk

(Sharecast News) - AstraZeneca on Monday announced that its Farxiga treatment against heart failure risk in certain patient groups has received approval from the US Food and Drug Administration.

Today 07:16

Login to your account

Don't have an account? Click here to register.